radiological agent shows promise in heavily treated mcrpc - medpage today
Published 5 years ago • 6 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
3:32
disease control with cabozantinib plus atezolizumab in crpc - medpage today
-
3:09
aua: surgery works in locally advanced prostate cancer
-
1:36:35
use of novel hormonal agents and systemic therapy in advanced prostate cancer highlights (2018)
-
1:26
current standards and future prospects for the treatment of hormone refractory prostate cancer
-
5:10
on-off therapy works in prostate cancer
-
0:38
emerging combinatory immunotherapies show promise for mcrpc
-
6:18
how to beat castration-resistant prostate cancer today
-
15:58
understanding intermittent hormone therapy for #prostatecancer | #markscholzmd #alexscholz #pcri
-
26:01
metastatic castrate-resistant prostate cancer: options and possible sequences
-
1:52:37
aua2019 048ic novel agents & concepts in the management of hormone naïve & crpc
-
54:57
monthly case webinar with dr. imran lasker episode #29
-
3:33
prophecy trial: ar-v7 ctcs as a biomarker in mcrpc
-
3:16
asco gu: higher-priced prostate therapy taking over
-
3:55
ipatential150 shows promise of ipatasertib addition in some mcrpc patients | christopher sweeney
-
5:42
advanced prostate cancer treatments on the horizon
-
27:02
mcrpc: latest developments in diagnostics and combination therapies
-
7:17
understanding metastatic castration-resistant prostate cancer
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
5:49
aua: drug slows bone mets in prostate cancer
-
3:09
mcrpc: sequencing therapy
-
9:31
promising agents for the treatment of prostate cancer
-
2:49
winship study of recurrent prostate cancer shows promise